Results 161 to 170 of about 43,310 (310)
Gene therapy for epilepsy: An emerging, promising approach for a serious neurological disorder
Abstract Gene therapy is emerging as a groundbreaking strategy for treating epilepsy, offering new hope to patients who do not respond to conventional medications. Despite advancements in anti‐seizure treatments, nearly 30%–40% of individuals with epilepsy continue to experience uncontrolled seizures, highlighting the urgent need for more effective and
Marco Ledri, Merab Kokaia
wiley +1 more source
Randomized controlled trial of mailed Nicotine Replacement Therapy to Canadian smokers: study protocol [PDF]
John Cunningham +5 more
openalex +1 more source
Nicotine Replacement Therapy [PDF]
openaire +1 more source
Representation of the suggested mode of action of lactoferrin (Lf) in nonsmall cell lung cancer (NSCLC) A549 cells. Lf induces activation of caspase‐3 by activating p53 and AChE leading to decreased ACh concentrations. In turn, ACh signaling leads to activation of VEGF and AKT and blocking of caspase‐3.
Stuti Goel +9 more
wiley +1 more source
MAMAWEL is introduced as the first calibration‐free potentiometric sensor for at‐home mastitis diagnosis. By measuring the sodium‐to‐potassium ratio in breast milk, the device reliably differentiates between healthy and mastitis‐affected samples with less than 10% error.
Ali Soleimani +9 more
wiley +1 more source
E-cigarettes helped more smokers quit than nicotine replacement therapy [PDF]
Rob Cook, Peter Davidson, Rosie Martin
openalex +1 more source
This review highlights recent advances in label‐free optical biosensors based on 2D materials and rationally designed mixed‐dimensional nanohybrids, emphasizing their synergistic effects and novel functionalities. It also discusses multifunctional sensing platforms and the integration of machine learning for intelligent data analysis.
Xinyi Li, Yonghao Fu, Yuehe Lin, Dan Du
wiley +1 more source
Knowledge, attitude and practices of institution-based dentists toward nicotine replacement therapy
Gaurav Sharma +2 more
openalex +1 more source
GLP‐1RA use improves outcomes post partial nephrectomy in T2DM patients with RCC: A TriNetX study
Abstract Objectives The purpose of this study is to investigate the impact of Glucagon‐like peptide‐1 receptor agonists (GLP‐1RAs) use on 90‐day postoperative outcomes and overall survival following partial nephrectomy (PN) for renal cell carcinoma (RCC), where type 2 diabetes mellitus (T2DM) is a common comorbidity.
Sam Kwon +7 more
wiley +1 more source

